本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Eledon Pharmaceuticals, Inc.

2.87
-0.0200-0.69%
盤後2.870.00000.00%16:05 EDT
成交量:19.15萬
成交額:56.03萬
市值:1.72億
市盈率:-3.85
高:3.09
開:3.00
低:2.86
收:2.89
資料載入中...
2022/03/24

重要事件披露

8-K - Current report
2022/03/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/28

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

重要事件披露

8-K - Current report
2022/01/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/19

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/09

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/07/02

重要事件披露

8-K - Current report
2021/06/16

重要事件披露

8-K - Current report
2021/05/18

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/04/27

重要事件披露

8-K - Current report
2021/04/12

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]